Scarica l'app Stockscreener
2.84
0.35%
-0.01
Pre-mercato:
3.38
0.54
+19.01%
Orchestra Biomed Holdings Inc Borsa (OBIO) Ultime notizie
Orchestra BioMed Reports 2024 Financial Results and Advances Cardiovascular Therapy - MSN
Orchestra BioMed’s Strategic Advances in Medical Innovations - TipRanks
What is B. Riley’s Estimate for OBIO Q1 Earnings? - Defense World
Chardan Capital Has Strong Outlook for OBIO FY2025 Earnings - Defense World
Orchestra BioMed (NASDAQ:OBIO) Upgraded at B. Riley - Defense World
HC Wainwright Has Lowered Expectations for Orchestra BioMed (NASDAQ:OBIO) Stock Price - Defense World
H.C. Wainwright cuts Orchestra BioMed stock target to $12 By Investing.com - Investing.com Australia
Where Orchestra BioMed Hldgs Stands With Analysts - Benzinga
Health Check: How Prudently Does Orchestra BioMed Holdings (NASDAQ:OBIO) Use Debt? - simplywall.st
HighTower Advisors LLC Has $274,000 Stock Holdings in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
Orchestra BioMed (NASDAQ:OBIO) Earns Buy Rating from Chardan Capital - Defense World
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q4 Loss, Lags Revenue Estimates - MSN
Orchestra BioMed (NASDAQ:OBIO) Posts Earnings Results, Hits Estimates - MarketBeat
BTIG maintains $12 target on Orchestra BioMed stock By Investing.com - Investing.com Canada
BTIG maintains $12 target on Orchestra BioMed stock - Investing.com Australia
OBIO stock touches 52-week low at $3.63 amid market challenges By Investing.com - Investing.com South Africa
OBIO stock touches 52-week low at $3.63 amid market challenges - Investing.com Australia
Orchestra BioMed Reports Full Year 2024 Financial Results and Provides a Fourth Quarter Business Update - The Manila Times
Orchestra BioMed Secures $30M Funding While Advancing Key Clinical Trials Despite Wider Losses - Stock Titan
(OBIO) Trading Advice - news.stocktradersdaily.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Freightos And 2 Other Penny Stocks Worth Watching - simplywall.st
Orchestra BioMed (NASDAQ:OBIO) Research Coverage Started at BTIG Research - ETF Daily News
Orchestra BioMed (NASDAQ:OBIO) Coverage Initiated at BTIG Research - The AM Reporter
BTIG Initiates Coverage of Orchestra BioMed Holdings (OBIO) with Buy Recommendation - Nasdaq
BTIG sets Orchestra BioMed stock with $12 target By Investing.com - Investing.com Australia
Insiders In Orchestra BioMed Holdings Left Out From 10% Price Rise After Disposing Stock - simplywall.st
BTIG Initiates Orchestra BioMed at Buy With $12 Price Target -March 20, 2025 at 07:15 am EDT - Marketscreener.com
Orchestra BioMed (OBIO) Projected to Post Earnings on Wednesday - Defense World
Orchestra BioMed (NASDAQ:OBIO) Given Buy Rating at HC Wainwright - Defense World
H.C. Wainwright maintains $14 target on Orchestra BioMed stock By Investing.com - Investing.com South Africa
Promising Clinical Developments and Strategic Advancements Drive Buy Rating for Orchestra BioMed Holdings - TipRanks
Dr. Vivek Reddy Joins Orchestra BioMed to Lead Breakthrough Hypertension Study - MSN
Orchestra BioMed Highlights Strategic Initiatives and Innovations - TipRanks
Orchestra BioMed to Participate in Upcoming Investor Conferences - MSN
Orchestra BioMed Updates Executive Compensation Policies - TipRanks
Orchestra BioMed Welcomes Christopher Cleary to Board of Directors - MSN
Orchestra BioMed to Present at Upcoming Investor Conferences - GlobeNewswire
3 Major Healthcare Conferences Where Orchestra BioMed Will Share Its Growth Story - StockTitan
Orchestra BioMed Appoints Vivek Reddy, M.D. as Executive - GlobeNewswire
Mount Sinai's Top Cardiac Expert Takes Helm of Groundbreaking Hypertension Treatment Study - StockTitan
0.15%
4.32%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):